Picard Medical, Inc. (PMI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Picard Medical, Inc. (PMI) has a cash flow conversion efficiency ratio of -1.155x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.38 Million) by net assets ($3.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Picard Medical, Inc. balance sheet quality to measure how much of total assets are equity-financed.
Picard Medical, Inc. - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Picard Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore PMI operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Picard Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Picard Medical, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Javelin Minerals Ltd
AU:JAV
|
-0.059x |
|
Vision Sigma
TA:VISN
|
-0.017x |
|
Crown Lifters Limited
NSE:CROWN
|
0.022x |
|
oodash Group AB (publ)
ST:OODA
|
N/A |
|
Robot S.A.
MC:RBT
|
0.077x |
|
Dantax
CO:DANT
|
-0.091x |
|
Sunrise New Energy Co. Ltd
NASDAQ:EPOW
|
-0.678x |
|
Salona Cotspin Limited
NSE:SALONA
|
0.248x |
Annual Cash Flow Conversion Efficiency for Picard Medical, Inc. (2022–2025)
The table below shows the annual cash flow conversion efficiency of Picard Medical, Inc. from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see PMI market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.79 Million | $-15.67 Million | -4.136x | -926.87% |
| 2024-12-31 | $-23.74 Million | $-11.87 Million | 0.500x | -83.29% |
| 2023-12-31 | $-3.55 Million | $-10.63 Million | 2.994x | +417.42% |
| 2022-12-31 | $11.37 Million | $-10.72 Million | -0.943x | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more